Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.38 |
| ▸ | MAOB | P27338 | 4/20 | 0.37 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | RAD52 | P43351 | 1/20 | 0.34 |
| ▸ | GFER | P55789 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL684100 | 1.00 | DAO (0.38) | DAOKDM4EMAOBKDM1ACHRNA7 | |
| SCHEMBL6660826 | 1.00 | DAO (0.38) | DAOKDM4EMAOBKDM1ACHRNA7 | |
| SCHEMBL24510605 | 0.93 | CHRNA7 (0.35) | DAOKDM4EMAOBKDM1ACHRNA7 | |
| SCHEMBL25452984 | 0.91 | HRH3 (0.40) | DAOKDM4EMAOBKDM1AALDH1A1 | |
| SCHEMBL24315691 | 0.91 | SIGMAR1 (0.42) | DAOKDM4ESIGMAR1 | |
| SCHEMBL2603311 | 0.91 | SIGMAR1 (0.46) | DAOKDM4EMAOBKDM1ASIGMAR1 | |
| SCHEMBL20621670 | 0.89 | KDM4E (0.39) | DAOKDM4EMAOBKDM1ACHRNA7 | |
| SCHEMBL24021744 | 0.87 | KDM4E (0.36) | DAOKDM4EMAOBKDM1ACHRNA7 | |
| SCHEMBL19545878 | 0.85 | KDM4E (0.35) | DAOKDM4EMAOBKDM1ACHRNA7 | |
| SCHEMBL27009985 | 0.84 | SIGMAR1 (0.41) | KDM4ECHRNA7SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160030599-A1 | PARTICLES COMPRISING LUMINESCENT LANTHANIDE COMPLEXES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2016-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160030599-A1 | PARTICLES COMPRISING LUMINESCENT LANTHANIDE COMPLEXES | SLC7A5, PDLIM5, LAGE3 | DAO 712/4885KDM4E 938/4885MAOB 808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.